The evidence is mixed1 supporting, 2 against, 1 worth knowing
Supporting
trading 11% above its 200-day average
Against
down 12% over twelve months
1 of the scans it matches has historically underperformed the market
Worth knowing
revenue fell 1% year on year in the quarter ending 2026-06-30
What would change this read: a close below 184, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
read from the filings, with the figure behind every line
Working2
Profit rose year on year in all 4 of the last 4 quarters.
4
Net profit +5.2% year on year, Rs 17 cr to Rs 18 cr.
+5.2%Rs 17 crRs 18 cr
Needs watching
Nothing in the filings stands out either way.
Every figure here is computed from the company’s own filings. The wording is generated directly from the figures.
How it has performed
price return over each window, measured against zero
What the scans say today
3 of 47 matched on 2026-08-21
20MICRONS matches 3 of the 47 scans today, across 2 different kinds of evidence.
20MICRONS trades at 11× trailing earnings, below its median of 12× over this window — 11% less expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
M&A filings were typically +0.23pt vs the market over the next 5 sessions (n=981) · Other filing filings were typically -0.08pt vs the market over the next 5 sessions (n=12,093) · AGM / EGM filings were typically +0.00pt vs the market over the next 5 sessions (n=4,362)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
profit rose 5% year on year
net margin widened from 6.7% to 7.3%
Going against it
revenue fell 1% against the same quarter a year earlier
revenue rose in 1 of the last 4 quarters
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
2026-06-30 · consolidated
245
24
18
5.04
7.3%
Q4 FY26
2026-03-31 · consolidated
261
25
18
4.99
6.7%
Q3 FY26
2025-12-31 · consolidated
215
20
15
4.24
6.9%
Q2 FY26
2025-09-30 · consolidated
231
23
17
4.92
7.5%
Q1 FY26
2025-06-30 · consolidated
247
23
17
4.78
6.8%
Q4 FY25
2025-03-31 · consolidated
227
19
15
4.31
6.7%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average+3.4%
Versus 200-day average+11.0%
Below 52-week high-12.5%
Above 52-week low+53.4%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)60.8
Higher closes in last 53 of 5
Six-month return+15.79%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.